Navigation Links
Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
Date:2/10/2011

ed in such response may not satisfy the FDA; the FDA may request other information prior to or after Arena resubmits the lorcaserin NDA or approval of the lorcaserin NDA; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner Arena or others expect or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersJack Lief

David Schull, PresidentPresident and CEO

david.schull@russopartnersllc.com858.717.2310Cindy McGeeManager, IR and Corporate Communications

Anthony J. Russo, Ph.D., CEO858.453.7200, ext. 1479

tony.russo@russopartnersllc.com212.845.4251www.arenapharm.com
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
2. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
3. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
4. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
5. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
6. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
7. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
8. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
9. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
10. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
11. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  The U.S. pet medications market is a ... retailers have entered the fray intent on gaining ... industry,s most important channel—veterinary clinics. Expert projections forecast ... slow showing as recently as 2013 to experience ... will grow from its 2013 level of $7.6 ...
(Date:6/3/2015)... , June 02, 2015 Research and Markets ... "Europe CT Market - Growth, Trends And Forecasts ... Computed tomography (CT) is an imaging process that ... exhaustive images, or scans, of areas inside the body. ... tomography (CAT) scanning. It is primarily used in the ...
(Date:6/2/2015)... ZURICH , June 3, 2015 ... information is the Internet. As markets become ever more ... a fact Haselmeier AG recognised long ago. Its maxim ... new standards in networking and digitisation. The ... for its pioneering "state of the art" technology and ...
Breaking Medicine Technology:U.S. Pet Medications Market to Reach $10 Billion by 2018, Remains Hotbed for Intense Competition, finds Reports by Packaged Facts and the FTC 2U.S. Pet Medications Market to Reach $10 Billion by 2018, Remains Hotbed for Intense Competition, finds Reports by Packaged Facts and the FTC 3Europe CT Market Report 2015-2019 - Growth, Trends And Forecasts 2
... SETAUKET, N.Y., Aug. 8 Lixte,Biotechnology Holdings, Inc. ... from each of two different types of drugs ... brain cancers have,activity against human pancreatic cancers in ... President and CEO of Lixte, said, "Lixte previously,reported ...
... Bile Acid-Derived Small Molecules ... Diseases, NEW YORK, Aug. 7 Historically, ... that regulate the absorption of,dietary lipids and cholesterol ... acids have broader systemic endocrine,functions, acting as important ...
Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 3
(Date:6/3/2015)... June 03, 2015 Array Health ... technology, has announced that CEO Jonathan Rickert will present ... on June 4, 2015. The session will address ... are disrupting traditional business models in health care, and ... , WHAT: Digital Transformation and the Health Care ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 Alberto ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Global Connector Award that annually recognizes one DIA ... has advanced the mission of DIA to foster innovation ...
(Date:6/3/2015)... June 03, 2015 VeoMed and ... expand online and mobile access to premier Continuing ... Maintenance of Certification (MOC) activities. ... innovative courses to Decker’s extensive lists of physicians, ... purchasing access to VeoMed’s premier online and live-streamed ...
(Date:6/3/2015)... 03, 2015 A group of nine ... with a Global Inspire Award at DIA’s upcoming Annual ... outstanding volunteers for their leadership, level of excellence, and ... , The recipients of the Author(s) of the Year ... whose article has made a significant impact in advancing ...
(Date:6/3/2015)... 03, 2015 Justina Molzon, MS Pharm, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Excellence in Service Award that recognizes the “Member of ... DIA volunteer and who has contributed to the advancement ...
Breaking Medicine News(10 mins):Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... poultry made its way to the food chain via the ... strain// of bird flu in early February this year. ... almost 850 tons of turkey had to pass through the ... the interim period between outbreak of the avian influenza and ...
... Haikerwal, today urged more Australians to donate blood and donate ... ,Dr Haikerwal said the AMA strongly supports the ... designed to raise the number of Australian blood donors and ... year. ,“Blood donors save lives,” Dr Haikerwal ...
... are varied reactions to the U.S panel hearing ... , The Senate Health, Education, Labor and ... Food and Drug Administration legal authority to approve alternative ... Yet it has drawn both brickbats and ...
... article published in the prestigious international journal 'The Lancet' by ... Darwin// has revealed a breakthrough in the battle to treat ... the worlds population. ,There are two major strains ... attention focuses on the more virulent P. falciparum, vivax malaria ...
... in a duck farm in Chonan, in central South Korea. ... bird flu on Thursday//. The cause was identified as "highly ... bird flu outbreak since November reported in South Korea. H5N1 ... Korea. ,The culling of over 55,000 poultry will ...
... According to statistics over one lac people Indians are diagnosed ... die as they do not get timely treatment. ... Check-up package in connection with World Kidney Day-2007. The camp ... and urine analysis for random glucose and creatinine. ...
Cached Medicine News:Health News:Generic Biologics – U.S Panel Hearing Draws Mixed Response 2Health News:Researchers Discover Breakthrough in Malaria Treatment 2
... manual autoclaves set the standard for steam ... to compliment any healthcare and laboratory facility. ... of your sterilization needs. Time tested reliability ... product. The Tuttnauer M Series is also ...
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms....
... The Isoseeds I-125 are brachytherapy sources which ... of localized tumors, especially in the prostate. ... the conclusion of the therapeutic effect, i.e. ... are intended for single use. They are ...
Non-sterile oncoseed seeds consists of a welded titanium capsule containing....
Medicine Products: